文献速递浆细胞疾病

E2F2通过转录调控PECAM1调节多发性骨髓瘤细胞黏附

E2F2 modulates cell adhesion through the transcriptional regulation of PECAM1 in multiple myeloma.
PubMed 文献 · Br J Haematol · 2023-06-26

本研究探讨E2F2在多发性骨髓瘤(MM)中的分子机制。高E2F2表达与MM患者较差总生存期和晚期临床分期相关;功能实验显示E2F2抑制细胞黏附并激活上皮-间质转化和迁移,通过与PECAM1启动子结合抑制其转录活性;沉默E2F2可抑制MM细胞活力和异种移植小鼠模型中的肿瘤进展。

要点

  • 高E2F2表达与MM患者较差总生存期和晚期临床分期相关
  • E2F2通过结合PECAM1启动子抑制其转录活性,进而抑制细胞黏附
  • 沉默E2F2可抑制MM细胞活力和异种移植小鼠模型中的肿瘤进展

核心结论

  • E2F2通过抑制PECAM1依赖性细胞黏附并加速MM细胞增殖发挥肿瘤促进因子的重要作用。
  • E2F2可能作为MM潜在的独立预后标志物和治疗靶点。

研究设计与样本

  • 研究采用功能获得和功能缺失实验、启动子相互作用实验以及MM细胞模型和异种移植小鼠模型。

主要发现

  • 高E2F2表达与MM患者较差总生存期和晚期临床分期相关。
  • E2F2抑制细胞黏附并激活细胞上皮-间质转化和迁移。
  • E2F2与PECAM1启动子相互作用以抑制其转录活性。
  • E2F2敲低介导的细胞黏附促进作用被PECAM1表达抑制显著逆转。
  • 沉默E2F2分别显著抑制MM细胞模型中的细胞活力和异种移植小鼠模型中的肿瘤进展。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Multiple myeloma (MM) is the second most common haematological malignancy. Despite the development of new drugs and treatments in recent years, the therapeutic outcomes of patients are not satisfactory. It is necessary to further investigate the molecular mechanism underlying MM progression. Herein, we found that high E2F2 expression was correlated with poor overall survival and advanced clinical stages in MM patients. Gain- and loss-of-function studies showed that E2F2 inhibited cell adhesion and consequently activated cell epithelial-to-mesenchymal transition (EMT) and migration. Further experiments revealed that E2F2 interacted with the PECAM1 promoter to suppress its transcriptional activity. The E2F2-knockdown-mediated promotion of cell adhesion was significantly reversed by the repression of PECAM1 expression. Finally, we observed that silencing E2F2 significantly inhibited viability and tumour progression in MM cell models and xenograft mouse models respectively. This study demonstrates that E2F2 plays a vital role as a tumour accelerator by inhibiting PECAM1-dependent cell adhesion and accelerating MM cell proliferation. Therefore, E2F2 may serve as a potential independent prognostic marker and therapeutic target for MM.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Chen SN, Mai ZY, Mai JN, et al. E2F2 modulates cell adhesion through the transcriptional regulation of PECAM1 in multiple myeloma. Br J Haematol. 2023. PMID: 37365680. doi:10.1111/bjh.18958

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。